ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001167.1|Piricyclamide_1 # 1 # 138 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	BGC0001167.1|Piricyclamide_1 	1	138	+	Loose	600	20.7866	THIN-B	44.44	3000851	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	THIN-B beta-lactamase	CGTAACTCTGCTCCCGTCCAACGGGAAAATGCCGCTACCGTCTCTCGTGATGGCAATGCGATCGCCCCTCAATGGATTCTGTTGGCCGACGGTACGCGGCCAAAAAATGCTCCTTTTGCGGGAGACGACGCAGAGTAA	RNSAPVQRENAATVSRDGNAIAPQWILLADGTRPKNAPFAGDDAE	MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTAGLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAALQAASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDAIKLGPLNLTAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGDGPDISASFAASIAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKERGVALPAAAPAAQHAH	14.24	gnl|BL_ORD_ID|1309|hsp_num:0	1393		
BGC0001167.1|Piricyclamide_2 # 387 # 542 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.532	BGC0001167.1|Piricyclamide_2 	387	542	+	Loose	650	21.1718	MexH	25.0	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAACCAAGAAACTGACACCCCGTAACTCTGCTCCCGTCCAACGGGAAAATGCCGCTACCGTCTCTCGTGATGGCAATGCGATCGCCCCGAATAATGAGTTTATGCAGACAGGGAGTTACAGCGGTCCTTTTGCGGGAGACGACGCGGAGTAA	MKTKKLTPRNSAPVQRENAATVSRDGNAIAPNNEFMQTGSYSGPFAGDDAE	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	13.78	gnl|BL_ORD_ID|1265|hsp_num:0	1344		
BGC0001167.1|Piricyclamide_3 # 792 # 1682 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.324	BGC0001167.1|Piricyclamide_3 	792	1682	+	Loose	1900	26.9498	mexN	35.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAGTTGCTGAGATTCAAAAAAACTCCCTCAAAGAGCAAAGAATAAAATTTATCCGTAATCATCAACAAGCTTTTGATGTTGAGCCGATTTATCCTCTGCGGCTGTTTGAAGACTTTGTAATGAGTGTTGAGGGTGACTGTAGTATTGAAGCTTCTTGTAAAATAGAACTGGACAAATTAATTGCTTCACGGTTTATGCTATTCTTCAAAGATCAAGAGTGGGAAAAATATCTAACTCAATCTTTAGCTTTTTTTCGGCAAGTTGAAAACCGAGTTGGTGTTCAATTAGATTATTCTTTATTACAAAAATTTTTAGGACATAACTTTGACTTTAGCAAACTAGAAGTTCTCAGTGCTGGACTTGATTTAAGAACTAATTTAGCTGATTCTAGTTTAAAAATACACATTAGAATTAAAGATTATCCTGAAAAAATCAACCAAGCTTTATCATTAACTATTGATGGCGATGACTTGACAGCTGTACGGGATTTTCTGTCCGTAGTCGGCTTTGATTTTTATTTTGATGGTCGTAGTGCTATTGAAATTTATCCTGAAGTTAAAGAAGAAGATTTTTTCAAGCCAAAAACTCAAGAAAAGGTATGGCAACATTTGCCAAAATTTGTTTTAGAACCTCTTCAGGTTACAAATTTGTTTGGTTTTGGTTTTTCCAAAACTAATCATAATCCAGTGGTTTACTACCGTCTCAAAGGTCGTCAAGATTTAACCAATTATTTTAAAATCAATGATACAGCCCAAAGAGTTCACAGCTTTTATCAACATCAAGATATTTTACCTAATATGTGGGTAGGTACTACTCAAAAAGAATTAGAAAAAACGAGAATTGAGAATATTCGGCTTTATTATTACAAATCCTTCAAGATGGAGTAA	MIVAEIQKNSLKEQRIKFIRNHQQAFDVEPIYPLRLFEDFVMSVEGDCSIEASCKIELDKLIASRFMLFFKDQEWEKYLTQSLAFFRQVENRVGVQLDYSLLQKFLGHNFDFSKLEVLSAGLDLRTNLADSSLKIHIRIKDYPEKINQALSLTIDGDDLTAVRDFLSVVGFDFYFDGRSAIEIYPEVKEEDFFKPKTQEKVWQHLPKFVLEPLQVTNLFGFGFSKTNHNPVVYYRLKGRQDLTNYFKINDTAQRVHSFYQHQDILPNMWVGTTQKELEKTRIENIRLYYYKSFKME	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	28.57	gnl|BL_ORD_ID|2066|hsp_num:0	2217		
BGC0001167.1|Piricyclamide_4 # 1688 # 2152 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.342	BGC0001167.1|Piricyclamide_4 	1688	2152	+	Loose	275	23.483	AAC(6')-Ib-SK	41.18	3002593	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTTGATGATAGAAGTAAATGAATTAAAACAACTCTATGACGTTGATGATGATCAATGGCTGGAACAAACTATTAACTTACTTAAAAATCATCAATTCCAACAGCTAGATTTAGATAATTTAATTGAGGAGTTAGAGGATTTGGGTAGAGAGAAGAAAAATGCTGTCGCTAGTCTGTTAGAGCAAATTATTCGTCATTTGCTGTTACTGCAATATTGGACAACTGAAGCCGAATATAATACTGTTCACCGGCAAGAAGAAATCTATAACTTTCGTACTCAACTGAGACGAACAATCACGACTAATCTCCGCAAGTATTTAAAAGATGAATTAACCTCTATCTATCAAGATGCGCTAGGTTTTGTTAAAATTAAAACAACTAATTTAGTAACTTTTCCTACTGAATGCCCCTACTCCCAAGAACAGTTACTTGATCGTTCTTGGTTGCCCAATCAAACCTATTAA	MLMIEVNELKQLYDVDDDQWLEQTINLLKNHQFQQLDLDNLIEELEDLGREKKNAVASLLEQIIRHLLLLQYWTTEAEYNTVHRQEEIYNFRTQLRRTITTNLRKYLKDELTSIYQDALGFVKIKTTNLVTFPTECPYSQEQLLDRSWLPNQTY	MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	87.50	gnl|BL_ORD_ID|967|hsp_num:0	1024		
BGC0001167.1|Piricyclamide_5 # 2208 # 2786 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.387	BGC0001167.1|Piricyclamide_5 	2208	2786	+	Loose	500	26.9498	OXA-205	31.11	3001483	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATTACCACCGAACCTATTATCTTAAACCTGAAAACCACCAATTTAAGTGACGAACAGTTTTATCAACTGTGCTGTGCTAATGACGATTGGCGACTCGAACAAACTGCCGAAGGAGAATTAATCATTATGCCTCCCATCGAAGCCATTAGTGGCAATCGAGAATCAGAATTAAATGCTGATTTAGTGATTTGGAATCGGCAAACTCAACTCGGTAAAGTTTTTAGTTCTTCTACTATCTTTACCTTGCCCAATGGCGCGAAACGTTCTCCTGATGTTGCTTGGATTGCCAATGAACGCTGGCACGCTTTACCCATAGAAGAACAAGAAAAATTTGCCAGAATTTGCCCAGATTTTGTGATAGAATTGCGATCGCGTACCGACCCCTTAAAATATCTACAAGAAAAAATGCAAGAATATCGAGAAAATGGTGTAAAATTAGGGTGGCTAATTGATCCTGCCAACCAAAGGTTAGAAATCTATCGCCCCAATCAATCTGTAGAAATTATTGAATTACCAGCAACATTATCAGGAGAAGAAATTTTACCTGGATTCACCTTAAAATTACCAATGTATTGA	MITTEPIILNLKTTNLSDEQFYQLCCANDDWRLEQTAEGELIIMPPIEAISGNRESELNADLVIWNRQTQLGKVFSSSTIFTLPNGAKRSPDVAWIANERWHALPIEEQEKFARICPDFVIELRSRTDPLKYLQEKMQEYRENGVKLGWLIDPANQRLEIYRPNQSVEIIELPATLSGEEILPGFTLKLPMY	MAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAEHALLVFGQERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNSAVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDGNLEISAHEQISFLRKLYRNQLPFQVEHQRLVKYLMITEAGRNWILRAKTGWEGRFGWWIGWVEWPTGPVFFALNIDTPNRTDDLFKREAIARAILRSIDALPPN	72.18	gnl|BL_ORD_ID|1478|hsp_num:0	1572		
BGC0001167.1|Piricyclamide_7 # 3494 # 5431 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.497	BGC0001167.1|Piricyclamide_7 	3494	5431	+	Loose	900	25.7942	otr(B)	26.0	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATTCCAGGATTGCAAGCATTACACAAACTAACCCAGGGTTCCCCAGAGATTACTGTTGCCATTCTTGATGGTGTCGTAGATACTCAACATCCCTGTTTTCAGGGAGCAAAATTAACTCGACTGCCCACCTTAGTATTACATGGTGCAACCAGTGGGCAGATGTCCACCCATGGGACTCATATTGCTAGTTTAATTTTTGGACAGCCTAATACAGAAATCGAAGGAATTGCCCCTCAGTGTCACGGTTTACTCGTGCCAGTTTTTTCCGATGACCGACGGCGACTATCTCAACTAGATTTAGCCCGTGCGATTGAACAAGCCGCCGAAAATGGAGCGCACATTATTAGTATTAGTGGGGGGGCGCTCACCGATATGGGAGAAGCAGAAGACTGGCTAGAGCGTGCCATTGAAATGTGTAGCCAGAGAAATATTCTTGTCGTTGCGGCTGCCGGAAATGATGGTTGCGAGTGCCTCCATGTTCCAGCCGCCCTTCCTGCTGTCCTAGCAGTGGGTGCTGTTGATGCTAGAGGGCATCCCCTCGACTTTAGTAATTGGGGGGAAACCTACCAAAATCAAGGCATCCTTGCCCCTGGAGAAAACATCTTAGGGGCAAAACCGGGCGGCGGGACAATACAAATGAGTGGCACTAGCTTCGCTGCGCCCATCGTAGCAGGAGTAGCGGCTTTATTATTCAGTTTGCAAGTGCAGCGGGGAGAAACACCTAATCCCCACGCAGTCAGGGAAGCACTACTAAAAAGCGCCCTTCCCTGTCAATATGCAGACAGTGAAAACGAACCAAAATGTTTAGCCGGCCTGTTGAACATTTCGGGGGCAATTAAACACCTAACCGGAGAAACCATGTCCGAAACCATAGAAACCCAAGCAACAGTAGAAGCTTCCGGCTGCGGCTGCGGTGGTACACCTGAAACCACCGAGGTTCAACGCCAAAATCTCGAACTGAGTGCCGCAACCAGCGCACCGGCAATCCCCGTTGTTGCCGCCCAAATTCCCAACCCTGTAACAACCTCTCAAGGAGTATCCATGCCTGAAACTACCACTAAATCTGTCACCCCTAGTCAAGCTGCTGAACCCGCTGGTGGAATCGTCTATGCCATTGGCACTTTGGGCTATGATTTCGGTACAGAAGCCCGTCGGGACACATTTAAACAACTGATGCCCACCGCCGTAATTGGAGGAATTGAAGTTCCCTCTAATCCCTACGATGCCCGCCAGATGGTGGATTATTTAGCCGATAACCTCTCAGAAGCCAAATCCTTAATCTGGACCCTGAACCTGGAACTTACCCCCATTTACGCCATTGAACCCCTCGGCTCTTTTTCCCGCGAAGTTTATTCGGCTTTACAGGAACTGCTTTCGGGACAAGTGCAAGCGGAAGACAGCCCCGAATATATCCAGCGTGTCAGTATTCCGGGACGGATTACTGGGCGCACAGTACGCCTGTTCTCAGGACAAGTTGTTCCCGTCATTGAACCGGATAGCCCCCGGGGAATTTATGGTTGGCACGTTAATACTTTAGTCCGTGCGGCAATAGAAGCTGTTGGTGCAGAACAAACAGAAGCCCAAGAAAGCCAAATGCGCCGCACTTTGAGTAGTTTCCTCAACCGCATCTACTACGATTTACGCAATTTAGGGCAAACTTCCCAAGACCGCGCCCTCAATTTTGCCGCGACCAATGCTTTCCAAGCAGCGCAAACTTTTTCTGAGGCTGTGGGTGCTGGGATGGAGTTAGATAGTATTAACGTTTCTAAGAGTCCTTTCTGTCGGCTGGATAGCGATTGTTGGGATGTACAGTTAAAATTCTTCGACCCAGAAAATAGCCGCCGCGCTCGTAAAGTATTCCGTTTTACTATAGATGTGAGTGATTTAATTCCTGTTACTTTGGGCGAGGTTCGTTCCTGGTCTTCTCCTTATTAG	MIPGLQALHKLTQGSPEITVAILDGVVDTQHPCFQGAKLTRLPTLVLHGATSGQMSTHGTHIASLIFGQPNTEIEGIAPQCHGLLVPVFSDDRRRLSQLDLARAIEQAAENGAHIISISGGALTDMGEAEDWLERAIEMCSQRNILVVAAAGNDGCECLHVPAALPAVLAVGAVDARGHPLDFSNWGETYQNQGILAPGENILGAKPGGGTIQMSGTSFAAPIVAGVAALLFSLQVQRGETPNPHAVREALLKSALPCQYADSENEPKCLAGLLNISGAIKHLTGETMSETIETQATVEASGCGCGGTPETTEVQRQNLELSAATSAPAIPVVAAQIPNPVTTSQGVSMPETTTKSVTPSQAAEPAGGIVYAIGTLGYDFGTEARRDTFKQLMPTAVIGGIEVPSNPYDARQMVDYLADNLSEAKSLIWTLNLELTPIYAIEPLGSFSREVYSALQELLSGQVQAEDSPEYIQRVSIPGRITGRTVRLFSGQVVPVIEPDSPRGIYGWHVNTLVRAAIEAVGAEQTEAQESQMRRTLSSFLNRIYYDLRNLGQTSQDRALNFAATNAFQAAQTFSEAVGAGMELDSINVSKSPFCRLDSDCWDVQLKFFDPENSRRARKVFRFTIDVSDLIPVTLGEVRSWSSPY	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	114.56	gnl|BL_ORD_ID|910|hsp_num:0	870		
BGC0001167.1|Piricyclamide_8 # 5512 # 5769 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.442	BGC0001167.1|Piricyclamide_8 	5512	5769	+	Loose	500	23.483	NDM-20	32.26	3004863	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGCCCGAATGCTTCGCCCCTACCCCCATTATTTACCCGAAAACAACCATGAGACTTCCCAAACAGTCTGCTCCCGTCAAACGTCCCCATTTTATTCATCCCCATGAATGCGTCGATATTATTCACGGTGATGGCGAAGACTTGGTATCTATCTTAGTTAAGTTAGTTCATGGAGCTAACTACAATGATCCGGCTCAGTTTCAATACCCTCACTATGGCTATCTGAAAATGTCCTCTTTTGGCGGTTTTCGTTATTAG	MPECFAPTPIIYPKTTMRLPKQSAPVKRPHFIHPHECVDIIHGDGEDLVSILVKLVHGANYNDPAQFQYPHYGYLKMSSFGGFRY	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLH	31.48	gnl|BL_ORD_ID|2724|hsp_num:0	3661		
BGC0001167.1|Piricyclamide_9 # 5816 # 6037 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.428	BGC0001167.1|Piricyclamide_9 	5816	6037	+	Loose	500	23.8682	OXY-1-4	46.43	3002392	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	ATGGCTAACTCTAAAAGTTCTAAGCAATCAGAAACCAATCCGAATGTTGAGCAACCAGAAACAAAAAAATCCAACATTCAACCACAGGAAACAACTCAACCTAAAGCTAAATATATTCCCGCAACTGGGTTAGAAGATTACGGACGCTGGAAATTGATGTTCCAAGACCGCAAGGCGACTCCCAATGATCCGCCGTTTCGTCGGGGTCGAATTTGGTGTTAA	MANSKSSKQSETNPNVEQPETKKSNIQPQETTQPKAKYIPATGLEDYGRWKLMFQDRKATPNDPPFRRGRIWC	MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL	25.17	gnl|BL_ORD_ID|1393|hsp_num:0	1481		
BGC0001167.1|Piricyclamide_10 # 6159 # 6314 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.494	BGC0001167.1|Piricyclamide_10 	6159	6314	+	Loose	300	20.7866	APH(3')-IX	46.15	3004087	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAAAACCCCAAAACTGACCCCTCGCATTACCGCCCCGGTTCAACGAGACAACATCGCTACTGTTCCTAGTGATGGTAATGTGATTACCCCTGCTACCTTCTGTGATTTAGCCACCAAGCAATGTTATCCCTTTGCGGGTGACGACGCAGTGTAA	MKTPKLTPRITAPVQRDNIATVPSDGNVITPATFCDLATKQCYPFAGDDAV	MINDMKISLPQSLKSFIGNQPLQKDKVGQSPSDVYSFTKNNEKYYLKTTELIYAQTTYSIIREAKILDWLDGKLNVPELVLMDTDHENEYMISKAVPAKPLQDFTGKSDQFFIDIYTDALAQLQSISIKNCPFISNKKFRLAEAEFFIENGLLDELDDDEKDLKLWSSYQNFAEFLDDLKQQNFQEEYVFSHGDLTDSNVFLSHDAQIYFLDVGRAGIADRFVDIAFIERSLREDCSEDAALQFLNHLAEDDSFKRNYFLKLDELN	19.17	gnl|BL_ORD_ID|2445|hsp_num:0	2751		
